Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer.
Inflammation and cancer have been viewed as closely linked for many years. This link is not merely a loose association but causative. In colorectal cancer (CRC), chronic inflammation as observed in inflammatory bowel (IBD) disease is a key predisposing factor and IBD-associated CRC comprises five percent of all CRCs. Although the molecular mechanisms linking IBD with CRC are not well understood, recent results obtained in preclinical models point to the transcription factor NF-kappaB as a central player. On the one hand, NF-kappaB regulates the expression of various cytokines and modulates the inflammatory processes in IBD. On the other, NF-kappaB stimulates the proliferation of tumor cells and enhances their survival through the regulation of anti-apoptotic genes. Furthermore, it has been clearly established that most carcinogens and tumor promoters activate NF-kappaB, while chemopreventive agents generally suppress this transcription factor. Actually, several lines of evidence suggest that activation of NF-kappaB may cause cancer. These include the finding that NF-kappaB genes can be oncogenes, and that this transcription factor controls apoptosis, cell-cycle progression and proliferation, and possibly also cell differentiation.
Schottelius
Arndt J
AJ
Development Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Dinter
Harald
H
D017209:Apoptosis; D002448:Cell Adhesion; D002453:Cell Cycle; D002470:Cell Survival; D018890:Chemoprevention; D015179:Colorectal Neoplasms / Q000276:immunology* / Q000503:physiopathology*; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D007249:Inflammation; D008264:Macrophages / Q000276:immunology; D016328:NF-kappa B / Q000276:immunology*; D009362:Neoplasm Metastasis; D009857:Oncogenes; D012307:Risk Factors; D014157:Transcription Factors
D016207:Cytokines; D016328:NF-kappa B; D014157:Transcription Factors